Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 94 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

10 trials in Phase 3/4

Results Transparency

4%

1 of 26 completed trials have results

Key Signals

39 recruiting1 with results

Enrollment Performance

Analytics

N/A
35(53.8%)
Phase 2
20(30.8%)
Phase 3
5(7.7%)
Phase 4
5(7.7%)
65Total
N/A(35)
Phase 2(20)
Phase 3(5)
Phase 4(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (94)

Showing 20 of 94 trials
NCT06589154Completed

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

Role: collaborator

NCT06509919Suspended

Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer

Role: collaborator

NCT07721532Active Not Recruiting

Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

Role: collaborator

NCT05470777Phase 2Active Not Recruiting

CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL

Role: collaborator

NCT07490405Not Yet Recruiting

Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism

Role: lead

NCT07585773Not Yet Recruiting

Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

Role: lead

NCT07585786Not Yet Recruiting

Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)

Role: lead

NCT07588334Not Yet Recruiting

Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)

Role: lead

NCT07588373Not Yet Recruiting

Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)

Role: lead

NCT05300516Not ApplicableCompleted

Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection

Role: lead

NCT07462091Not ApplicableRecruiting

Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection

Role: lead

NCT07461545Not ApplicableRecruiting

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS

Role: lead

NCT07461532Not ApplicableRecruiting

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Role: lead

NCT07161466Not ApplicableCompleted

Effects of Positive End-Expiratory Pressure Levels on Lung Recruitment Duration and Hemodynamics After Alveolar Recruitment Maneuver: A Randomized Clinical Trial

Role: lead

NCT05376111Phase 2Recruiting

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

Role: collaborator

NCT06220162Phase 2Recruiting

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Role: collaborator

NCT07463300Recruiting

A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging

Role: collaborator

NCT07383103Phase 4Recruiting

Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock

Role: lead

NCT06746181Not ApplicableCompleted

Effect of Different Inspired Oxygen Concentrations on Intraoperative Recruitment Outcomes in Patients Undergoing Abdominal Surgery

Role: lead

NCT07324785Recruiting

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

Role: lead